πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,444 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8809292

Compositions and methods for inhibiting expression of the PCSK9 gene

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8808866

Coated elastomeric article and method for making a coated elastomeric article

Precision Components, Inc. Β· Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8802090

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic canc

PRECISION BIOLOGICS, INC. Β· Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8796444

Methods and compositions for the specific inhibition of gene expression by double-stranded

INTEGRATED DNA TECHNOLOGIES, INC. Β· Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8791250

Compositions and methods for inhibiting expression of the HAMP gene

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8785609

Cloning and expression of HTLV-III DNA

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8784780

High oil-content emollient aerosol foam compositions

Precision Dermatology, Inc. Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8781750

Cell-type-specific patterns of gene expression

The Regents of the University of California Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8779094

Low viscosity highly concentrated suspensions

The Board of Regents of the University of Texas System Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8771731

Antimicrobial nanoemulsion compositions and methods

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8765932

Compositions and methods for inhibiting expression of XBP-1 gene

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8765813

Use of treprostinil to treat and prevent ischemic lesions

United Therapeutics Corporation Β· Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8758755

Stem cell fusion model of carcinogenesis

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8759301

Gene fusion targeted therapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8754030

Defensin-antigen fusion proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8748114

ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphom

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8747872

Nanoemulsion therapeutic compositions and methods of using the same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8740615

Implant, implant body, and abutment body

Nanto. Precision Co., Ltd Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8741866

Compositions and methods for inhibiting expression of transthyretin

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8741589

Monitoring two dimensions of diabetes pathogenesis

The Regents of the University of California Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8735382

Infusion and injection solution of levodopa

Dizlin Medical Design AB Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8735369

Compositions and methods for inhibiting expression of a gene from the Ebola virus

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8728532

Ischemia/reperfusion protection compositions and methods of using

Regents of the University of Minnesota Β· Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8728524

Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the preventi

Anika Therapeutics S.r.l. Β· Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted